Announcements Trials
Browse Landscape

Phase

Phase 2 5Phase NA 2Phase 4 2Phase 3 2Phase EARLY_PHASE1 1Phase 1 1

Status

Unknown 1Completed 1

Sponsor Class

OTHER 9INDUSTRY 6OTHER_GOV 2UNKNOWN 1

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 2

Conditions

Lung Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Adenocarcinoma of Lung 1

Interventions

human papillomavirus vaccine, L1 type 16, 18 3Radiotherapy 3Propranolol 3Cisplatin 3entecavir 2Tranexamic Acid 2Pemetrexed 2Metformin 2Erythromycin 2Epinephrine 2Cyclophosphamide 2Chemoradiotherapy 2Bortezomib 2ulipristal acetate 1tislelizumab 1plerixafor 1lobaplatin 1ledipasvir 1eribulin 1endostar protein 1dolutegravir 1colistinmethanesulfonic acid 1cetrorelix 1acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 1XELOX 1Vancomycin 1Vacuum Curettage 1Vaccination 1Suction 1Sofosbuvir 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 4 × OTHER_GOV × Pemetrexed × Clear all
NCT02804646 2016-06-21

Endostar Durative Transfusion Combined With Chemotherapy in the Treatment of Advanced Lung Adenocarcinoma

Anhui Provincial Hospital

Phase 4 Unknown
100 enrolled
Thoracic

Adenocarcinoma of Lung

NCT01442909 2011-09-29

Pemetrexed Followed by Docetaxel or in Reverse Sequence

Taipei Veterans General Hospital, Taiwan

Phase 4 Completed
44 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡